Aerobid and Haematocrit abnormal - a phase IV clinical study of FDA data

Summary:

Haematocrit abnormal is reported as a side effect among people who take Aerobid (flunisolide), especially for people who are male, 60+ old, also take Compazine, and have Diarrhea.

The phase IV clinical study analyzes which people have Haematocrit abnormal when taking Aerobid. It is created by eHealthMe based on reports of 1,123 people who have side effects when taking Aerobid from the FDA, and is updated regularly.

What is Aerobid?

Aerobid has active ingredients of flunisolide. eHealthMe is studying from 1,126 Aerobid users. Check the latest studies of Aerobid.

What is Haematocrit abnormal?

Haematocrit abnormal is found to be associated with 279 drugs and 595 conditions by eHealthMe. Check the latest studies of Haematocrit abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

1,123 people reported to have side effects when taking Aerobid.
Among them, 23 people (2.05%) have Haematocrit abnormal.

Could Aerobid cause Haematocrit abnormal?

Among these 23 people:

What is the gender of people who have Haematocrit abnormal when taking Aerobid? *

female: 0.0 %
male: 100 %

What is the age of people who have Haematocrit abnormal when taking Aerobid? *

What are other drugs people take besides Aerobid? *

What are other side effects people have besides Haematocrit abnormal? *

Fatigue (feeling of tiredness): 23 people, 100.00%
X-Ray Abnormal: 22 people, 95.65%
Exostosis (formation of new bone on the surface of a bone): 22 people, 95.65%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 22 people, 95.65%
Osteoporosis (bones weak and more likely to break): 22 people, 95.65%
Osteopenia (a condition where bone mineral density is lower than normal): 22 people, 95.65%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 22 people, 95.65%
Oral Pain: 22 people, 95.65%
Muscle Spasms (muscle contraction): 22 people, 95.65%
Muscle Aches (muscle pain): 22 people, 95.65%

What are the existing conditions these people have? *

Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 22 people, 95.65%
Multiple Myeloma (cancer of the plasma cells): 22 people, 95.65%
Mood Swings (an extreme or rapid change in mood): 22 people, 95.65%
Joint Pain: 22 people, 95.65%
High Blood Pressure: 22 people, 95.65%
High Blood Cholesterol: 22 people, 95.65%
Fluid Retention (an abnormal accumulation of fluid in the blood): 22 people, 95.65%
Diarrhea: 22 people, 95.65%
Seasonal Allergy (allergic condition due to certain season): 18 people, 78.26%
Blood Triglycerides Decreased: 18 people, 78.26%

* Approximation only. Some reports may have incomplete information.

Do you take Aerobid and have Haematocrit abnormal?

- Check whether Haematocrit abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aerobid:

Aerobid (1,126 reports)

Browse all side effects of Aerobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematocrit abnormal:

Haematocrit abnormal (279 drugs)

Browse all the conditions that are associated with Haematocrit abnormal:

Haematocrit abnormal (595 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on flunisolide (the active ingredients of Aerobid) and Aerobid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.